ArticleScientific reports2024

CRISPR/Cas9 genome editing of CCR5 combined with C46 HIV-1 fusion inhibitor for cellular resistant to R5 and X4 tropic HIV-1.

Wannisa Khamaikawin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.